Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy-GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study

Radiation therapy is an integral part of the multimodal primary therapy of glioblastomas. As the overall prognosis in this tumor entity remains unfavorable, current research is focused on additional drug therapies, which are often accompanied by increases in toxicity. By using proton beams instead o...

Full description

Saved in:
Bibliographic Details
Main Authors: König, Laila (Author) , Jäkel, Cornelia (Author) , Knebel Doeberitz, Nikolaus von (Author) , Kieser, Meinhard (Author) , Eberle, Fabian B. (Author) , Münter, Marc (Author) , Debus, Jürgen (Author) , Herfarth, Klaus (Author)
Format: Article (Journal)
Language:English
Published: 20 December 2021
In: Radiation oncology
Year: 2021, Volume: 16, Pages: 1-7
ISSN:1748-717X
DOI:10.1186/s13014-021-01962-8
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13014-021-01962-8
Get full text
Author Notes:Laila König, Cornelia Jäkel, Nikolaus von Knebel Doeberitz, Meinhard Kieser, Fabian Eberle, Marc Münter, Jürgen Debus, Klaus Herfarth
Description
Summary:Radiation therapy is an integral part of the multimodal primary therapy of glioblastomas. As the overall prognosis in this tumor entity remains unfavorable, current research is focused on additional drug therapies, which are often accompanied by increases in toxicity. By using proton beams instead of photon beams, it is possible to protect large parts of the brain which are not affected by the tumor more effectively. An initial retrospective matched-pair analysis showed that this theoretical physical benefit is also clinically associated with a reduction in toxicity during therapy and in the first few months thereafter.
Item Description:Gesehen am 23.02.2022
Physical Description:Online Resource
ISSN:1748-717X
DOI:10.1186/s13014-021-01962-8